BMC Res Notes. 2026 Jul 24;19(1):383. doi: 10.1186/s13104-025-07487-7.
ABSTRACT
BACKGROUND: Ischemic stroke (IS), a leading global health problem, is caused by interrupted blood flow in the brain, often due to clotting or artery constriction. Long non-coding RNAs (lncRNAs), particularly HOX transcript antisense intergenic RNA (HOTAIR), are pivotal in stroke pathophysiology.
AIM: This study focused on the expression levels of HOTAIR lncRNA in ischemic stroke patients.
METHODS AND MATERIALS: This comparative cross-sectional study with 100 participants: 50 IS patients and 50 patients without IS serving as controls. The study gathered demographic data, disease specifics, and medication history. Blood samples were analyzed for HOTAIR lncRNA expression levels.
RESULTS: This study showed significantly higher expression levels of HOTAIR lncRNA among IS patients compared to the control group (5.73 ± 0.75 vs. 2.35 ± 0.29; P < 0.001), with an average increase of 3.19 units compared to the control group (P < 0.001) after adjusting the independent variables. Additionally, participants with hypertension had an average increase of 0.36 units in of HOTAIR lncRNA expression compared to the control group (P = 0.041).
CONCLUSION: Our study found that HOTAIR lncRNA levels are significantly higher in IS patients and may be associated with a history of hypertension. diseases. This suggests that HOTAIR lncRNA could be a useful biomarker for stroke and related conditions.
PMID:42902418 | DOI:10.1186/s13104-025-07487-7